DrugPatentWatch Database Preview
Custopharm Inc Company Profile
What is the competitive landscape for CUSTOPHARM INC, and what generic and branded alternatives to CUSTOPHARM INC drugs are available?
CUSTOPHARM INC has six approved drugs.
Summary for Custopharm Inc
| US Patents: | 0 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 6 |
| Patent Litigation for Custopharm Inc: | See patent lawsuits for Custopharm Inc |
Drugs and US Patents for Custopharm Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Custopharm Inc | FLUDARABINE PHOSPHATE | fludarabine phosphate | INJECTABLE;INJECTION | 076349-001 | Aug 28, 2003 | AP | RX | No | No | See Pricing | See Pricing | ||||
| Custopharm Inc | VALRUBICIN | valrubicin | SOLUTION;INTRAVESICAL | 206430-001 | Apr 19, 2019 | AO | RX | No | No | See Pricing | See Pricing | ||||
| Custopharm Inc | GANCICLOVIR SODIUM | ganciclovir sodium | INJECTABLE;INJECTION | 212001-001 | Jun 20, 2019 | AP | RX | No | No | See Pricing | See Pricing | ||||
| Custopharm Inc | PENTOBARBITAL SODIUM | pentobarbital sodium | INJECTABLE;INJECTION | 203619-001 | Nov 13, 2017 | AP | RX | No | No | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
